article thumbnail

What sets the Drugs to Watch in 2024 apart

Clarivate

Clarivate data indicates a 90% probability that datopotamab deruxtecan will win marketing authorization in the United States, and projects 2029 sales of $2.7 billion in 2029 for CASGEVY alone. FDA accelerated approval in August, Clarivate projects the drug will see $850 million in sales by 2029. billion in 2029 revenues.

2024 59
article thumbnail

Unlocking U.K. research excellence: Key insights from the Research Professional News Live summit

Clarivate

From discussions on REF2029 to the imperatives of fostering diversity, innovation and research integrity, we explored the future of research amidst financial challenges and evolving policies. Together, we can pave the way for a brighter future of research and innovation, advancing a new era in research and learning.

2029 64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Rise of Plant Based Alternatives

Maru Group

billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period of 2022 to 2029’ – C5 Group Inc ) Even a look at the chilled cabinets in the supermarket and you’ll see the evidence – but are people engaged with this and to what extent?

2029 15
article thumbnail

Outsource Accounts Payable: Save Time and Reduce Costs

Magellan Solutions

The accounts payable outsourcing services market is projected to reach a staggering multimillion-dollar valuation by 2029. Outsourcing allowed P&G to focus its internal resources on core business activities, such as product innovation and marketing. It could be your business’s game-changing solution.

2029 52
article thumbnail

How to Enhance CX in Retail With Customer Feedback?

SurveySensum

The issues could be – declining product or service quality, lack of innovation or outdated offerings, unfavorable customer service experiences, or uncompetitive pricing compared to alternatives. Embrace innovation: Be open to incorporating innovative solutions, technologies, and strategies that align with customer demands.

Retail 52
article thumbnail

Medication Price Controls: Pharma vs. the Federal Government

2020 Research

The bill would allow Medicare to negotiate prices on up to 60 drugs by 2029, starting with 10 in 2026. Any Concerns Over Limits in Innovation With Price Controls? Will innovation be stifled to provide more affordable care for the masses? Time will tell. Have a Research Project in Mind? Our experts are here to help.

article thumbnail

Medication Price Controls: Exploring the Inflation Reduction Act and Pharma’s Legal Battle with The Federal Government

2020 Research

The bill would allow Medicare to negotiate prices on up to 60 drugs by 2029, starting with 10 in 2026. Any Concerns Over Limits in Innovation With Price Controls? Will innovation be stifled to provide more affordable care for the masses? Time will tell. Do You Have a Research Project in Mind? Our experts are here to help.